“…The therapeutic targets should include the following: a) neutralization of circulating (i.e., not bound to receptors) toxins; b) the elimination of the toxin-producing source (i.e., the vegetative C. tetani forms); and in particular, c) management of clinical features using ventilation, nutrition and hemodynamic support in addition to treatment of muscle spasms. (6,(10)(11)(12)(13) Neutralizing toxin activity Unbound tetanus toxin can be found in organ fluids, in particular, in blood and tissues surrounding the wound. For neutralization purposes, heterologous anti-tetanus serum (ATS) or hyperimmune human tetanus immunoglobulin (TIG) should be administered as soon as possible, ideally before the tetanus toxin has begun its axonal migration toward the spinal cord, after which neutralization is no longer possible.…”